CBS 2019
CBSMD教育中心
English

动脉粥样硬化性心血管疾病

科研文章

荐读文献

Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association Metabolic Interactions and Differences between Coronary Heart Disease and Diabetes Mellitus: A Pilot Study on Biomarker Determination and Pathogenesis Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization The contribution of tissue-grouped BMI-associated gene sets to cardiometabolic-disease risk: a Mendelian randomization study Primary Prevention of Sudden Cardiac Death From Focal Lipid Storage to Systemic Inflammation Identifying coronary artery disease patients at risk for sudden and/or arrhythmic death: remaining limitations of the electrocardiogram Clinical Risk Factors and Atherosclerotic Plaque Extent to Define Risk for Major Events in Patients Without Obstructive Coronary Artery Disease: The Long-Term Coronary Computed Tomography Angiography CONFIRM Registry In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events

Review ArticleApril 15, 2020

JOURNAL: Article Link

The Science Underlying COVID-19: Implications for the Cardiovascular System

PP Liu, A Blet, D Smyth et al. Keywords: COVID-19; pre-existing cardiovascular disease; ACE2 receptor; organ dysfunction;

Full Text PDF